VAERS Reports U006596

VAERS 2415949

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

moderat

Staat: CA
Alter: 4,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 18.08.2022
Beginn: 18.08.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Body temperature increased Chest X-ray normal Dyspnoea Enterovirus test positive Human rhinovirus test positive

Symptomtext

Patient presented to ED about 5 hours after vaccine with shortness of breath and temperature 100.4

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: CXR normal, nasal swab positive for rhinovirus/enterovirus
Aktuelle Erkrankungen: none
Vorgeschichte: congenital atrial septal defect
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2110304

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u006596

moderat

Staat: MD
Alter: 14,0
Geschlecht: F
Eingang: 14.02.2022
Impfdatum: 14.02.2022
Beginn: 14.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Aphasia Dyskinesia Dyspnoea Pallor Tremor

Symptomtext

Signed consent and center enrolment form obtained. VIS provided, student denies any allergies, and No past medical history. At 11:00am IZs IPV, HBV, Tdap, MCV, MMR and Varicella administered, student stated that she is having difficulty of breathing. Assessed student. At 11:10 student c/o difficulty breathing, B/P 85/57, HR 83, RR 26, O2 Sat 96% alert, oriented to time, place, and person. Pupils equal, round, and reactive to light, Lungs clear bilaterally, Student continue complaining of SOB, lower lip pale, fingers bilaterally pale. Mild Diaphysis 11:23am Epinephrine, (Auto-injectors) 0.3 mg administered by NP. Student started shaking, difficulty to verbalize, facial expression were symmetrical, strong grips bilaterally, and strong bilateral extremities movements. 11:30am normal skin color BP 96/65 HR 80 O2 sat 100%, student stated her breathing is improved. Alert and oriented, School administers, student?s guardian notified, EMS call initiated, student?s guardian notified. EMT arrived brief report given, student transferred to Hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2418263

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

mild

Staat: MI
Alter: 5,0
Geschlecht: M
Eingang: 23.08.2022
Impfdatum: 17.08.2022
Beginn: 20.08.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pyrexia Swelling face

Symptomtext

received call from mother of client reporting that client had swelling on right side of jaw that started on saturday (8/20/22) after receiving vaccinations on 8/17/22. she reports that swelling is still present in right side of jaw. She took client to dentist for exam and he told her to contact Health Department that gave immunizations. Dentist prescribed amoxicillin for swelling in jaw. Mother reports she will set up apt with PCP. clients mother reports low grade fever of 99.3 also on Saturday after vaccinations. she denies any other symptoms. client was not taking any medications at time of vaccinations and does not have any allergies. client does not have any preexisting conditions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none per mother
Vorgeschichte: none
Andere Medikamente: none per mother
Allergien: none per mother
Vorherige Impfungen: -

VAERS 2386759

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

mild

Staat: MD
Alter: 1,0
Geschlecht: M
Eingang: 22.07.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SC / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Pyrexia SARS-CoV-2 test negative

Symptomtext

Developed fever up to 101 on same day as vaccine administration. Maintained Fever For 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: COVID TEST - NEGATIVE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2305313

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

mild

Staat: OH
Alter: 1,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 16.05.2022
Beginn: 30.05.2022
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Rash Rash erythematous Rash macular

Symptomtext

Patient developed diarrhea and broke out in a rash 16 days after the vaccinations. erythematous macular rash primarily centrally at the time of visit. NO vesicles, petechiae or purpura. No fevers. the rash just starting to show at the ankle but sparing of the palms and soles.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2283172

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006596

mild

Staat: TX
Alter: 1,6
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 04.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pyrexia Rash macular Varicella

Symptomtext

On 5/5/22 , 1 day after the vaccines were given, red dots appeared all over the patients body, face and hands. Mom stated it looked like a Varicella outbreak. He also had fever. This continued for 3 days then it went away on its own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2189051

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

mild

Staat: VA
Alter: 1,0
Geschlecht: M
Eingang: 19.03.2022
Impfdatum: 07.03.2022
Beginn: 12.03.2022
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SC / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Laboratory test Rash Urticaria

Symptomtext

03/12/2022, 5 days post vaccination, Family reports rash on child. No SOB, no lip or tongue swelling reported. 03/16/2022 Follow up appointment for rash. 03/16/2022 Per Dr., Start "Children's Benedryl 12.5mg/5ml @ 2.5ml PO Q4hrs PRN for hives for 30 days (300ml) no refill". 03/06/2022, Hospital admission to the Pediatric ER. Dx of VGE with emesis and diarrhea. Patient discharged to home with Zofran and directed to follow up with Provider.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: 03/07/2022 Routine labs ordered 03/08/2022 Labs resulted 03/16/2022 Referral to Allergist
Aktuelle Erkrankungen: 03/06/2022, Hospital admission to the Pediatric ER
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA and NKFA
Vorherige Impfungen: -

VAERS 2624122

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: NE
Alter: 1,2
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.03.2023
Beginn: 03.03.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Vaccine expiration date was 03/01/2023. Vaccine was administered after expiration date. Given on 03/03/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Tylenol
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2604299

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 28.03.2023
Impfdatum: 03.03.2023
Beginn: 03.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE; LVN reporting a dose of MMRII with a labeled expiry of 3/1/2023 was inadvertently administered to a patient on 3/3/2023.; This spontaneous report was received from licensed practical nurse and refers to a female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 03-MAR-2023, the patient was inadvertently vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 ml, lot #U006596, expiration date: 01-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided). No additional adverse events reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2593427

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: OR
Alter: -
Geschlecht: U
Eingang: 08.03.2023
Impfdatum: 03.03.2023
Beginn: 03.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported; Medical assistant reported that a dose of MMR II was inadvertently administered after its labeled expiry date. The involved MMR II expired on 3/1/2023 and was administered on 3/3/2023. The DILUENT used to reconstitute the MMR II was not expired.; This spontaneous report has been received from other health professional (medical assistant) concerning to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications included: sterile diluetnt (MERCK STERILE DILUENT). On 03-MAR-2023, the patient was inadvertently administered a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) subcutaneous injection, at a dose of 0.5 milliliter (ml) (strength, and route of administration were not provided; lot number U006596 that was verified to be valid, expiration date reported and established as01-MAR-2023) for prophylaxis, after it was labeled expiry date (expired product administered). It was reported that the diluent used to reconstitute the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not expired (strength, dose, oral route of administration was not provided; lot number W026513 that was verified to be valid, expiration date reported and established as 15-APR-2025). No additional adverse event (AE) reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: MERCK STERILE DILUENT
Allergien: -
Vorherige Impfungen: -

VAERS 2439320

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 10.09.2022
Impfdatum: -
Beginn: 19.08.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event Product storage error

Symptomtext

No additional AEs; Caller reported vaccines administered after temperature excursio; the vaccines were administered IM (instead of SQ}.; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 19-AUG-2022, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, lot #U028164, expiration date: 09-SEP-2023; and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, 0.5 ml, lot #U006596, expiration date: 01-MAR-2023 (vaccination schedules were not provided) both administered intramuscularly for prophylaxis (Product storage error, Incorrect route of product administration). The vaccines were stored in 32.9 Fahrenheit degrees (F) in a time frame of 28 hours and 39 minutes. It was reported the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was stored within recommended range for this reported excursion. The vaccines had undergone previous excursion in 20.7 F in a time frame of 32 hours and 10 minutes. No additional adverse events were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2208USA008668:dpoc# 02231010 US-009507513-2208USA010122:dpoc# 02231010 US-009507513-2208USA009718:dpoc# 02231010 US-009507513-2208USA008558:dpoc# 02231010

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2426122

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 10.09.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event Product storage error

Symptomtext

No additional AEs; Caller reported vaccines administered after temperature excursion. Caller also unable to provide information on prior temperature excursions. During data collection- Caller reported the vaccines were administered IM (instead of SQ). No additional; Vaccines were administered IM (instead of SQ); This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies were not reported. On 16-AUG-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX)at a dose of 0.5 ml lot #U028164, expiration date: 09-SEP-2023, administered intramuscularly instead of subcutaneously (incorrect route of administration) for prophylaxis following a temperature excursion of 32.9 degrees Fahrenheit for 28 hours and 39 minutes (product storage error), it was stated that previous temperature excursions did occurred. No additional adverse event was reported. This is one of several case from the same reporter.; Sender's Comments: US-009507513-2208USA008668: US-009507513-2208USA010122: US-009507513-2208USA008558:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2426119

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 01.09.2022
Impfdatum: 17.08.2022
Beginn: 17.08.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event Product storage error

Symptomtext

No additional AEs; the vaccines were administered IM (instead of SQ).; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. Information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant therapies was not provided. On 17-AUG-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin) (M-M-R II) as prophylaxis (lot number U006596 has been verified to be valid, expiration date reported and established as 01-MAR-2023) 0.5 milliliters (ml) administered intramuscularly (IM) instead of subcutaneously (incorrect route of product administration). It was reported that measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin) (M-M-R II) was stored within recommended temperature range. No additional adverse events were reported (no adverse event). The patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (case # 2208USA008558). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2208USA008668: US-009507513-2208USA009718: US-009507513-2208USA008558: US-009507513-2208USA008497: US-009507513-2208USA008503: US-009507513-2208USA008699:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2421804

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 27.08.2022
Impfdatum: 15.08.2022
Beginn: 15.08.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration Product storage error

Symptomtext

no adverse event; vaccines administered after temperature excursion.; es were administered IM (instead of SQ).; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unspecified date in 2022, doses of varicella virus vaccine live (oka/merck) (VARIVAX) lot #U028164, expiration date: 09-SEP-2023; and doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) lot #U006596, expiration date: 01-MAR-2023 underwent a temperature excursion of 32.9 fahrenheit degrees during 28 hours and 39 minutes with previous temperature excursions. On 15-AUG-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U028164, expiration date: 09-SEP-2023, administered intramuscularly (Subcutaneous injection formulation administered by other route) (strength, dosage regimen, and anatomical location were not provided); and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) 0.5 milliliter, lot #U006596, expiration date: 01-MAR-2023, administered intramuscularly (Subcutaneous injection formulation administered by other route) (strength , dosage regimen, and anatomical location were not provided) as prophylaxis. No adverse event was reported. This is one of several cases reported by the same reporter.; Sender's Comments: US-009507513-2208USA008558: US-009507513-2208USA008497: US-009507513-2208USA008503: US-009507513-2208USA008699:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2421802

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 27.08.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event Product storage error

Symptomtext

No additional AEs; Caller reported vaccines administered after temperature excursio; the vaccines were administered IM (instead of SQ); This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 16-AUG-2022, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, lot #U028164, expiration date: 09-SEP-2023 (vaccination schedule was not provided) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, 0.5 ml, lot #U006596, expiration date: 01-MAR-2023 (vaccination schedule was not provided), both administered intramuscularly instead of subcutaneously for prophylaxis (Product storage error, Incorrect route of product administration). The vaccines underwent temperature excursion in 32.9 degrees Fahrenheit (F) in a time frame of 28 hours and 39 minutes. It was reported measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) was stored within recommended temperature range, however the vaccines underwent previous temperature excursion, for which reporter was unable to provide data. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2208USA008668:dpoc# 02230999 US-009507513-2208USA008497: US-009507513-2208USA008558: US-009507513-2208USA008699:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2399449

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: CA
Alter: 49,0
Geschlecht: F
Eingang: 02.08.2022
Impfdatum: 02.08.2022
Beginn: 02.08.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect route of product administration

Symptomtext

Pt was given vaccine as IM in left deltoid

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: Microgestin Fe 1.5/30
Allergien: Azithromycin
Vorherige Impfungen: -

VAERS 2137267

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: GA
Alter: 1,0
Geschlecht: M
Eingang: 24.02.2022
Impfdatum: 23.02.2022
Beginn: 23.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cough Dysphonia Rhinorrhoea Stridor Swelling face Swelling of eyelid

Symptomtext

Significant coughing, inspiratory stridor, hoarseness, runny nose, (facial) swelling of the right upper eye lid

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: No labs drawn after reaction
Aktuelle Erkrankungen: Positive COVID PCR test on 1/7/2022
Vorgeschichte: None
Andere Medikamente: None
Allergien: None Known
Vorherige Impfungen: -

VAERS 2131494

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: MI
Alter: 1,2
Geschlecht: F
Eingang: 22.02.2022
Impfdatum: 22.02.2022
Beginn: 22.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event Wrong product administered

Symptomtext

no adverse reactions, wrong vaccines administered at visit, only hep is given too early, no adverse reactions noted. mom informed and will continue to monitor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2092553

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006596

gering

Staat: AZ
Alter: 4,0
Geschlecht: F
Eingang: 07.02.2022
Impfdatum: 24.01.2022
Beginn: 24.01.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

The patient was giving an expired vaccine on the day of 01/24/2022. Varicella T002847 Expiration date 01/23/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -